Cystic Fibrosis

Excerpt

Cystic fibrosis is a chronic genetic disorder that has affected children and adults since ancient times, primarily affecting the respiratory, digestive, and reproductive systems. Important chronic manifestations of cystic fibrosis include chronic lung infections, pancreatic insufficiency, sinusitis, and infertility. Cystic fibrosis is often associated with shortened lifespans, and the most common cause of death is end-stage lung disease.

Historically misunderstood, cystic fibrosis gained recognition in folklore through the "salty skin" symptom, which symbolized an incurable condition. In medieval Europe, these children were believed to be cursed by witches and doomed to die. The curse that became folklore pronounced, "Woe to the child who tastes salty from a kiss on the brow, for he is cursed and soon will die." Salty skin was a sign of an impending illness without cause or cure. Until relatively modern times, cystic fibrosis was poorly understood.

Modern understanding began in 1949 when scientists identified the autosomal recessive inheritance pattern of cystic fibrosis and linked the disease to a defect in the CFTR protein, a chloride channel crucial for regulating salt and water balance in the body. Quinton postulated that sweat ducts in these patients were impermeable to chloride. Further studies led to the hypothesis that the faulty chloride channel must be situated in the apical membranes of the lung surface or glandular epithelium to explain the respiratory and systemic organ failure associated with cystic fibrosis.

Symptoms may appear in infancy, childhood, or adulthood, with newborn screening and genetic testing aiding early diagnosis. The disease is caused by over 2,000 possible mutations in the CFTR gene, each disrupting chloride ion transport, leading to thick mucus accumulation, organ dysfunction, and electrolyte imbalances.

Advancements in treatment include CFTR modulators like ivacaftor and lumacaftor, which address underlying protein defects, and supportive therapies targeting nutrition, airway clearance, and infection control. Despite progress, cystic fibrosis remains life-limiting, with lung transplantation serving as an option for end-stage disease. Interprofessional care focusing on improving lung function, managing complications, and optimizing quality of life is essential for those with cystic fibrosis.